Hospitals across Massachusetts showed significant financial losses in the first quarter of the year, capturing a time mostly before the coronavirus pandemic hit in full force, according to new state data released Thursday.
Researchers at UMass Medical School and Massachusetts General Hospital have announced a major breakthrough in ALS research: a therapy that suppresses a harmful gene that causes the nervous system disease.
Recipients skewed small, a reflection of both the predominance of small businesses and the aim of the Paycheck Protection Program, which generally leaves out public companies and all those with more than 500 employees.
The Massachusetts Department of Public Health is warning practitioners of a major spike in congenital syphilis, with more than twice as many babies born with the sexually transmitted infection last year than at any other point in the past two decades.
UMass Memorial Medical Center has begun a pilot testing program using saliva to test for the coronavirus, offering a new method in addition to the more common nasal swab.
Marlborough pharmaceutical firm Sunovion has announced promising results from a study for a bipolar disorder drug, sending development to a third phase of testing.
Business confidence in Massachusetts rebounded in June in lockstep with the reopening of economic sectors that had been sealed off by government order to guard against the spread of COVID-19.